SAN DIEGO — Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, and Pillar Biosciences Inc., the pioneers of Decision Medicine™, today announced a strategic partnership to make Pillar’s suite of oncology assays commercially available globally as part of the Illumina portfolio of oncology products. The agreement will result in an […]
Comprehensive cloud platform provides industry-leading data quality, security, privacy, and compliance for ongoing service that screens for more than 300 inherited conditions with automated annual re-analysis MOUNTAIN VIEW, Calif., and LA JOLLA, Calif. — DNAnexus Inc., the leading provider of cloud-based genomic and biomedical data access and companion analysis software, today announced that Fore Genomics, […]
Baylor College of Medicine to utilize spatial genomics tools to continue research into retinal disease CAMBRIDGE, Mass. — Vizgen, the life science company dedicated to improving human health by visualizing single-cell spatial genomics information, today announced that it has installed its 100th MERSCOPE instrument in the Single Cell Genomics Core at the Baylor College of Medicine Department of […]
ST. LOUIS — Thompson Street Capital Partners (TSCP), a private equity firm based in St. Louis, today announced the acquisition of Quanta BioDesign, the inventor of discrete polyethylene glycol (dPEG®) technology for advanced bioconjugate and payload delivery design for life science and biopharma applications, by Vector Laboratories, a portfolio company of TSCP and the pioneer […]
PTAB rejects request by Berkeley Lights to reconsider its decision denying Berkeley’s argument that AbCellera’s U.S. patent is invalid VANCOUVER, British Columbia — AbCellera (Nasdaq: ABCL) announced that the United States Patent and Trademark Office’s (USPTO) Patent Trial and Appeal Board (PTAB) has denied a rehearing request in an Inter Partes Review (IPR) filed by Berkeley […]
Rainer Perneker, who has been the CEO of Greiner Bio-One International GmbH since 2012, will step down as head of the division and leave the company effective August 28. Manfred Stanek, COO of Greiner AG, will take over as head of the medical products division on an interim basis until a successor is appointed. “Rainer […]
SAN DIEGO — Maravai LifeSciences Holdings, Inc. (“Maravai” or the “Company”) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, announced that Robert (“Chip”) Hance has stepped down from the Company’s Board of Directors (the “Board”) effective July 19, 2023, and that Dr. John DeFord has been appointed to […]
New partnership with Niba Labs to offer customized digital PCR (dPCR) assay design services to biopharma customers Launch of CGT Viral Vector Lysis Kit enabling standardized workflow from cell lysates to absolute and precise quantification of viral titers Biopharmaceutical companies increasingly adopting dPCR technology for enhanced drug safety and efficacy in drug development process Venlo, […]
Patent-pending bioprocess has the potential to produce tens of millions of quality-controlled organoids per batch SAN JOSE, Calif. – Molecular Devices, LLC., a leading high-performance life science solutions provider, continues industrializing biology with its organoid line expansion services to support next-generation drug discovery. The offering leverages proprietary bioreactor and bioprocess technology to scale up the production of […]
The gold standard in dsRNA detection now available to virology researchers worldwide Boston, MA. — Absolute Biotech, a new company uniting multiple antibody-centric brands into a single organization specializing in antibody reagents, kits and services, today announced the reintroduction of SCICONS™ dsRNA antibodies. Originally developed in 1990, SCICONS antibodies have become the gold standard in […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
